Status:

COMPLETED

Peer Support for Women With Heart Disease: Women@Heart

Lead Sponsor:

Ottawa Heart Institute Research Corporation

Conditions:

Coronary Heart Disease

Women's Health

Eligibility:

FEMALE

18+ years

Phase:

NA

Brief Summary

Women with heart disease are more likely to die or suffer another cardiac event or stroke within 5 years of an index event compared to men. They are also more likely to suffer depression and report lo...

Eligibility Criteria

Inclusion

  • Women who have been hospitalized at UOHI in the past year with stable CHD, including: AMI; stable angina with corroborating evidence of CHD; recent CABG; or percutaneous coronary intervention (to allow examination of mechanisms linking the intervention and psychosocial well-being with health and healthcare outcomes);
  • Women ≥ 18 years of age (the age of consent in Ontario);
  • Women able to read and understand English or French;
  • Women who reside in Ontario and are eligible for Ontario Health Insurance Plan (to permit linkage with administrative data housed at the Institute for Clinical Evaluative Sciences \[ICES\]);
  • Women available to participate over the next 6 months (the intervention and data collection takes place over this time frame -- reducing the probability of missing data);
  • Women able to provide informed consent.

Exclusion

  • Women who have been hospitalized primarily for valve replacement or repair, HF, pulmonary hypertension, endocarditis or pericarditis (to reduce heterogeneity and avoid confounding when examining mechanisms linking the intervention and psychosocial well-being with health and healthcare outcomes);
  • Women who, in the opinion of the UOHI clinical psychologist, manifest psychiatric illness or cognitive impairment that would preclude participation in W@H (i.e. they are unable to benefit from the intervention, to prevent disruption of other participants).

Key Trial Info

Start Date :

January 1 2018

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 17 2024

Estimated Enrollment :

180 Patients enrolled

Trial Details

Trial ID

NCT03286010

Start Date

January 1 2018

End Date

June 17 2024

Last Update

July 16 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Ottawa Heart Institute

Ottawa, Ontario, Canada, K1Y4M2